TCW Group Inc. Acquires 131 Shares of Colgate-Palmolive (NYSE:CL)

TCW Group Inc. grew its position in shares of Colgate-Palmolive (NYSE:CL) by 0.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,932 shares of the company’s stock after acquiring an additional 131 shares during the quarter. TCW Group Inc.’s holdings in Colgate-Palmolive were worth $1,448,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $43,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.7 %

Shares of NYSE CL opened at $90.10 on Tuesday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The business’s fifty day moving average price is $88.88 and its 200-day moving average price is $95.73. The stock has a market capitalization of $73.12 billion, a PE ratio of 25.60, a P/E/G ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 EPS. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Analyst Upgrades and Downgrades

CL has been the subject of several recent research reports. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. UBS Group cut their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Barclays cut their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.